Alzheimer Disease Blood Test Approved for Primary Care

In this episode, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Medical News Director Jennifer Abbasi discuss the journal's inaugural Research of the Year roundup. Related Content: Research of the Year 2025

Updates on coffee and AFib, a polypill approach for HFrEF, the first oral PCSK9 inhibitor, vitamin D supplementation for secondary prevention, and more: Joanna Chikwe, MD, chair of the American Heart Association's Scientific Sessions conference and of the Department of Cardiac Surgery in the Smidt Heart Institute at Cedars-Sinai Medical Center, shares clinical research highlights from the recent meeting. Related Content: Coffee and AFib, Oral PCSK9 Drugs, an HFrEF Polypill, and Vitamin D Post-MI—Highlights From AHA 2025

Correction: an earlier version of this podcast misstated the phosphorylated tau analyte measured by the Roche blood biomarker test. It is p-tau181, not p-tau217. In this week's roundup, JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Alzheimer Disease Blood Test Cleared for Primary Care, but Questions Remain About Its Use" and more. Related Content: Alzheimer Disease Blood Test Cleared for Primary Care, but Questions Remain About Its Use

In this week's roundup, JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "US Governors Are Forming a Public Health Alliance Amid Federal Funding Cuts and Shifting Guidance" and more. Related Content: US Governors Are Forming a Public Health Alliance Amid Federal Funding Cuts and Shifting Guidance

Updates on SGLT2 inhibitors, fish oil and hemodialysis, GLP-1 drugs, and more: Katherine R. Tuttle, MD, education committee co-chair of Kidney Week 2025 and a professor of medicine at the University of Washington, shares clinical research highlights from the recent meeting. Related Content: SGLT2 Inhibitors, Fish Oil in Hemodialysis, GLP-1 Drugs, and More—Highlights From Kidney Week

In this weekly roundup, JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "MASLD—The Chronic Liver Disease That Affects Tens of Millions of US Adults but Flies Under the Radar" and more. Related Content: Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults MASLD—The Chronic Liver Disease That Affects Tens of Millions of US Adults but Flies Under the Radar ------------------------ jamamedicalnews.com

In this weekly roundup, JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "Peanut Allergies Appear to Be on the Decline Following Early Introduction Guidelines" and more. Related Content: Peanut Allergies Appear to Be on the Decline Following Early Introduction Guidelines

Dementia is still a highly stigmatized condition. Nancy Berlinger, PhD, a senior research scholar at The Hastings Center for Bioethics, discusses a new report about the cultural narratives of dementia and how they can affect the quality of life and the care of patients with the condition. Related Content: Living With Dementia Report Emphasizes That Even Those With Advanced Disease Have Stories to Share

State Laws Aim to Bring Internationally Trained Physicians to Underserved Areas, but Barriers Abound; Oral Microbiome Composition Linked to Pancreatic Cancer Risk Related Content: Oral Microbiome Composition Linked to Pancreatic Cancer Risk State Laws Aim to Bring Internationally Trained Physicians to Underserved Areas, but Barriers Abound

A new European Society of Cardiology clinical consensus statement deals with cardiovascular disease prevention and management in COVID-19, including cardiac long COVID. The report's lead author, Vassilios Vassiliou, MBBS, PhD, MA, discusses the guidance and key questions that remain about COVID-19 and the heart. Related Content: New Guidance on Cardiovascular Disease and COVID-19—From Infection to Long COVID to Vaccination